Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Transcutaneous phrenic nerve stimulation to prevent diaphragm atrophy in ICU patients

Official title: Does Transcutaneous Phrenic Nerve Stimulation Prevent Diaphragm Atrophy?

Run by Bakirkoy Dr. Sadi Konuk Research and Training Hospital · NCT06897774 · Data updated 2026-11-12

This study is testing if a special electrical stimulation can help prevent diaphragm weakness in ICU patients on ventilators for a long time, making it easier for them to breathe on their own again.

More Critical Care, Intensive Care trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment80 (estimated)
SponsorBakirkoy Dr. Sadi Konuk Research and Training Hospital
Government
Locations1 site (Istanbul, Bakirkoy)
StatusRecruiting
StartedJanuary 22, 2024
Main results expectedApril 22, 2025
Study endsApril 22, 2025
Registry record updatedMarch 27, 2025
Trial IDNCT06897774 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are on invasive mechanical ventilation for 72 hours or more.

Probably not a fit

Patients under 18, those with certain medical conditions like neuromuscular diseases or severe obesity, and those requiring less than 72 hours of mechanical ventilation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effects of transcutaneous phrenic nerve stimulation on preventing diaphragm atrophy in patients requiring invasive mechanical ventilation for over 72 hours. Participants will receive electrical stimulation through the skin to contract the diaphragm muscle, with the aim of enhancing muscle function and facilitating earlier extubation. The study will evaluate diaphragm muscle condition using ultrasonography and collect various patient data during the intervention period. Conducted at a single center, the study aims to enroll a total of 80 patients over the course of one year.

Why it matters

Potential benefit: If successful, this approach could help ICU patients recover faster by preventing diaphragm atrophy and reducing the duration of mechanical ventilation.

How similar studies have gone: While the specific approach of transcutaneous phrenic nerve stimulation is novel, similar studies have shown promise in muscle preservation during mechanical ventilation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:Patients on invasive mechanical ventilation for 72 hours or more Patients older than 18 years

Exclusion Criteria: Patients under 18 years of age

* Patients with less than 72 hours of mechanical ventilation
* Pregnancy
* Patients with a body mass index above 35kg/m²
* Neuromuscular disease
* Refractory epilepsy
* Patients with pacemakers
* ARDS
* Unilateral or bilateral diaphragm paralysis
* Presence of pneumothorax
* Patients with large right pleural effusion
* Tracheostomized patients
* Patients undergoing upper abdominal surgery

Where it's running

  • Dr.SadiKonuk EAH
    Istanbul, Bakirkoy, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.